Sign Up to like & get
recommendations!
1
Published in 2022 at "ChemMedChem"
DOI: 10.1002/cmdc.202100778
Abstract: Although the farnesoid X receptor (FXR) has been regarded as a promising drug target for metabolic diseases as well as anti‐inflammatory, antitumor and antiviral actions, the antagonism by FXR ligands are still underrepresented in current…
read more here.
Keywords:
metastasis;
cell proliferation;
nsclc cell;
modification fxr ... See more keywords